Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/14/2007CN1930150A Pyrazolyl indolyl derivatives as PPAR activators
03/14/2007CN1930148A Polymorphic and amorphous forms of 2,5-dimethyl-2h-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((e)-2-pyridin-2-yl-vinyl)-1h-indasol-6-ylamino]-phenyl}-amide
03/14/2007CN1930147A Vla－4拮抗剂 Vla-4 antagonists
03/14/2007CN1930146A Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
03/14/2007CN1930145A Cycloalkanopyridine derivative
03/14/2007CN1930142A Antiinflammatory lactones
03/14/2007CN1930141A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
03/14/2007CN1930138A Substituted morpholine and thiomorpholine derivatives
03/14/2007CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists
03/14/2007CN1930131A 2H- or 3H-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
03/14/2007CN1930128A Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
03/14/2007CN1930127A Process for the synthesis of cxcr4 antagonist
03/14/2007CN1930126A 吡啶酮衍生物 Pyridine derivatives
03/14/2007CN1930125A Biphenyl compounds useful as muscarinic receptor antagonists
03/14/2007CN1930123A Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
03/14/2007CN1930122A 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
03/14/2007CN1929880A Bone grafting material, comprising a porous carrier and at least one pyrrolindone, a method for its production and an implant
03/14/2007CN1929864A Complex particles and coated complex particles
03/14/2007CN1929863A Antineoplastic combinations of CCI-779 and rituximab
03/14/2007CN1929861A CTGF as target for the therapy of diabetic nephropathy
03/14/2007CN1929850A Purified polyoxypropylene/polyoxyethylene copolymers and method of preparing the same
03/14/2007CN1929849A Liquid composition for bulging mucous membrane for use in endoscopic surgery comprising a chitosan derivative containing carbohydrate chains
03/14/2007CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection
03/14/2007CN1929847A Fasudil-containing preparation and method of improving stability thereof
03/14/2007CN1929846A Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases
03/14/2007CN1929845A Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
03/14/2007CN1929844A 毒蕈碱性乙酰胆碱受体拮抗剂 Muscarinic acetylcholine receptor antagonist
03/14/2007CN1929843A Composition for treating hyperlipoidemia
03/14/2007CN1929842A Use of camptothecin derivatives for the treatment of proliferative diseases in a fixed dosing regimen
03/14/2007CN1929841A Pharmaceutical composition of (+)-erythro-mefloquine and its use
03/14/2007CN1929840A 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation
03/14/2007CN1929839A Controlled release pharmaceutical composition of tolperisone for oral administration
03/14/2007CN1929838A Solid pharmaceutical preparation containing sparingly water-soluble drug
03/14/2007CN1929837A Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
03/14/2007CN1929836A (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
03/14/2007CN1929835A Treatment of aromatase inhibitor therapy-related osteoporosis
03/14/2007CN1929834A Indol-1-yl-acetic acid derivatives
03/14/2007CN1929833A Oxydecahydronaphthalene modulators of HM74
03/14/2007CN1929832A Use of metformin and orlistat for the treatment or prevention of obesity
03/14/2007CN1929831A Methods for altering insulin secretion
03/14/2007CN1929830A Combination of an NMDA receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other CNA disorders, and method therefor
03/14/2007CN1929829A (S)-2-N-propylamino-5-hydroxytetralin as a D3-agonist
03/14/2007CN1929828A Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic deseases
03/14/2007CN1929827A Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid
03/14/2007CN1929824A Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid
03/14/2007CN1929823A Sustained release torsemide dosage forms
03/14/2007CN1929821A Pharmaceutical composition comprising pimobendan
03/14/2007CN1929818A Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
03/14/2007CN1929817A Microemulsion formulations comprising particular substance P antagonists
03/14/2007CN1929816A Pharmaceutical compositions comprising midazolam in a high concentration
03/14/2007CN1929815A Compositions comprising mannose phosphate for vaginal treatment
03/14/2007CN1929737A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/14/2007CN1928115A Method for demonstrating efficacy of a topically applied active ingredient
03/14/2007CN1928112A Expression of VEGF I type receptor on blood vessel adventitia fibroblast
03/14/2007CN1928107A Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla)
03/14/2007CN1928089A Total genome of HIV virus
03/14/2007CN1927892A Lysine-chitosan resin and preparation method thereof
03/14/2007CN1927878A Clematis chinensis total saponin and treatment action thereof for rheumatoild disease
03/14/2007CN1927877A siRNA for inhibiting human Ezrin gene expression and expression carrier thereof
03/14/2007CN1927870A Novel ligand platinum compounds
03/14/2007CN1927862A Garcinia acid derivatives, preparation method and application thereof in pharmacy
03/14/2007CN1927861A Garcinia acid derivatives, preparation method and application thereof in pharmacy
03/14/2007CN1927858A Novel phenolic acid compounds of tanshin polyphenolic acid N and application thereof
03/14/2007CN1927854A Preparation method of potassium sodium dehydroandroan drographolide succinate, potassium sodium dehydroandroan drographolide succinate preparation and preparation method thereof
03/14/2007CN1927848A Substituted acid compounds, preparation method and medicament use thereof
03/14/2007CN1927841A Carbonyl additive derivative of geldanamycin benzoquinone, preparation method and use thereof
03/14/2007CN1927840A Aromatic reductive derivative of geldanamycin benzoquinone, preparation method and use thereof
03/14/2007CN1927815A Compound of o-benzylamino phenyl ether, derivative, preparation method and use of the same
03/14/2007CN1927399A Application of non-nucleoside virus reverse transcriptase inhibiting compound and derivative thereof for anti-hepatitis B virus purpose
03/14/2007CN1927398A Medicinal composition comprising active components of 5-HT 3 receptor antagonist and H2 receptor antagonist and use thereof
03/14/2007CN1927393A Composite collagen gel
03/14/2007CN1927392A Composite collagen eye drops
03/14/2007CN1927390A Compound recipe interferon vaginal spray for preventing and treating human viral infection
03/14/2007CN1927384A Lung lobe cleaning fluid
03/14/2007CN1927383A Compound recipe preparation for lowering oxidative stress rapidly and prepn. method therefor
03/14/2007CN1927381A Medicine comprising rilmenidine
03/14/2007CN1927380A Traditional Chinese medicine for treating dermatosis and its preparation
03/14/2007CN1927370A Baofukang vaginal soft capsule and its preparing process
03/14/2007CN1927369A Medicine for curing burn and scald wound and its preparation method
03/14/2007CN1927362A Traditional Chinese powder medicine for treating toothache
03/14/2007CN1927361A Nutritious health food for protecting liver and neutralizing the effect of alcohol and its preparation
03/14/2007CN1927360A Traditional Chinese medicine composition for treating skin inflammation
03/14/2007CN1927345A Antifungal liquid drug
03/14/2007CN1927336A Medicine for treating cancer
03/14/2007CN1927334A Garlic powder health care capsule for reducing blood lipids and method for preparing same
03/14/2007CN1927327A Composition comprising epalrestat
03/14/2007CN1927322A Liposoluble traditional medicine bougie for treating acute and chronic prostatitis, and manufacturing technique thereof
03/14/2007CN1927319A Traditional Chinese medicine composition for dredging meridian, activating blood circulation and removing stasis
03/14/2007CN1927313A Pharmaceutical composition for treating pharyngitis
03/14/2007CN1927311A Drug for treating chronic atrophic gastritis precancerous lesion and finished capsule product thereof
03/14/2007CN1927295A Eye protecting nutritious liquid
03/14/2007CN1927292A External use drug for treating burn, bedsore, chronic ulcer and etc. and preparation method thereof
03/14/2007CN1927290A Ointment for treating naevus and preparing method thereof
03/14/2007CN1927286A Chinese medicine composition for treating skin disease
03/14/2007CN1927285A Medicament for neutralizing the effect of alcohol and protecting liver
03/14/2007CN1927283A Chinese medicine bone pain or anesthesia caused by cold and dampness
03/14/2007CN1927278A Children's Shuangqing dispersant tablet and method for making same
03/14/2007CN1927274A Externally used drug for treating herpes zoster
03/14/2007CN1927271A Receptor smoking giving up plaster
03/14/2007CN1927270A Production process of five-ester droplet
1 ... 3841 3842 3843 3844 3845 3846 3847 3848 3849 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 ... 7860